| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |